3[1]van Leeuwen DJ, Wilson L, Crowe DR. Liver biopsy in the mid-1990s:questions andanswers. Semin Liver Dis, 1995, 15(4):340～359.
4[2]Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med, 2001, 344(7):495～500.
5[3]Stanley AJ, Haydon GH, Piris J, et al. Assessment of liver histology in patientswith hepatitis C and normal transaminase levels. Eur J Gastroenterol Hepatol, 1996,8(9):869～872.
6[4]Patrick L. Hepatitis C:epidemiology and review of complementary/alternativemedicine treatments. Altern Med Rev, 1999, 4(4):220～238.
7[5]Levine RA. Treating histologically mild chronic hepatitis C:monotherapy,combination therapy, or tincture of time? Ann Intern Med, 1998, 129(4):323～326.
8[6]Bach N, Thung SN, Schaffner F. The histologic effects of low-dose methotrexatetherapy for primary biliary cirrhosis. Arch Pathol Lab Med, 1998, 122(4):342～345.
9[7]Stotland BR, Lichtenstein GR. Liver biopsy complications and routineultrasound. Am J Gastroenterol, 1996, 91(7):1295～1296.
10[8]McMahon C, Pilkington R, Shea EO, et al. Liver biopsy in Irish hepatitisinfectedpatients with inherited bleeding disorders. Br J Haematol, 2000, 109(2):354～359.
5Suzuki Y, Arase Y, Ikeda K, et al. Clineal and pathologi- cal characteristies of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome [ J ]. J Gastroenterol Hepatol, 2004,19(6): 699-706.
